The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study

被引:75
|
作者
Graff-Guerrero, Ariel [1 ,2 ,3 ]
Mizrahi, Romina [1 ,2 ]
Agid, Ofer [1 ,2 ]
Marcon, Heidi [1 ]
Barsoum, Penny [1 ]
Rusjan, Pablo [1 ]
Wilson, Alan A. [1 ,2 ]
Zipursky, Robert [2 ,4 ,5 ]
Kapur, Shitij [1 ,2 ,6 ]
机构
[1] Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
[3] Univ Nacl Autonoma Mexico, Inst Neurobiol, Juriquilla, Queretaro, Mexico
[4] McMaster Univ, Dept Psychiat, Hamilton, ON L8S 4L8, Canada
[5] McMaster Univ, Dept Behav Neurosci, Hamilton, ON L8S 4L8, Canada
[6] Kings Coll London, Inst Psychiat, London SE5 8AF, England
基金
加拿大健康研究院;
关键词
schizophrenia; psychosis; C-11]-(+)-PHNO; D-3; D-2; high-affinity state; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; ENDOGENOUS DOPAMINE; AGONIST RADIOLIGAND; D2(HIGH) RECEPTORS; D-2/3; AGONIST; BINDING; AMPHETAMINE; RADIOTRACER; BRAIN;
D O I
10.1038/npp.2008.199
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The dopamine D-2 receptors exist in two states: a high-affinity state (D-2(high)) that is linked to second messenger systems, is responsible for functional effects, and exhibits high affinity for agonists; and a low-affinity state that is functionally inert and exhibits lower affinity for agonists. The dopamine D-3 receptors have high-affinity for agonist (eg dopamine) and the existence of the two affinity states is controversial. Although preclinical studies in animal models of psychosis have shown a selective increase of D-2(high) as the common pathway to psychosis, the D-3 has been suggested to be involved in the pathophysiology of psychosis. We report the first study of the D-2(high) and D-3 in schizophrenia using the novel PET radiotracer, [C-11]-(+)- PHNO. We recruited 13 patients with schizophrenia-spectrum disorder amidst an acute psychotic episode, drug free for at least 2 weeks, and 13 age - sex-matched healthy controls. The binding potential no-displaceable (BPND) was examine in the main regions of interest (caudate, putamen, ventral striatum, globus pallidus, substantia nigra, and anterior thalamus) and in a voxel-wise analysis. The BPND between patients and controls was not different in any of the regions. The voxel-wise analysis did not reveal any difference and no correlations were found between the BPND and positive and negative syndrome scale subscales. Our results do not find support for the hypothesis linking psychosis to a selective increase in D-2(high) and/or D-3 in schizophrenia. It is possible that receptors with high affinity are not accessible by [C-11]-(+)-PHNO because they are occupied by endogenous dopamine, a possibility that can be ruled out in future experiments.
引用
收藏
页码:1078 / 1086
页数:9
相关论文
共 50 条
  • [21] PET imaging of dopamine D3 receptors in humans with [11C]-(+)-PHNO: Validation using a selective D3 antagonist
    Searle, Graham
    Beaver, John
    Comley, Robert
    Bani, Massimo
    Tziortzi, Andri
    Slifstein, Mark
    Wilson, Alan
    Gunn, Roger
    Rabiner, Eugenii
    Laruelle, Marc
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [22] First quantification of D3 receptors in vivo:: PET with [11C]PHNO and [11C]fallypride
    Rabiner, Eugenii A.
    Slifstein, Mark
    Gunn, Roger N.
    Gentile, Gabriella
    Cunningham, Vincent J.
    Xu, Xiaoyan
    Huiban, Mickael
    Plisson, Christophe
    Laruelle, Marc A.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 11S - 11S
  • [23] Estimating Endogenous Dopamine Levels at D2 and D3 Receptors in Humans Using the Agonist Radiotracer [11C]-(+)-PHNO
    Caravaggio, Fernando
    Nakajima, Shinichiro
    Borlido, Carol
    Remington, Gary
    Gerretsen, Philip
    Wilson, Alan
    Houle, Sylvain
    Menon, Mahesh
    Mamo, David
    Graff-Guerrero, Ariel
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 378S - 378S
  • [24] Positron emission tomography quantification of [11C]-(+)-PHNO binding to the dopamine D2/D3 receptors in the human brain
    Ginovart, Nathalie
    Willeit, M.
    Rusjan, P.
    Graff, A.
    Vitcu, I.
    Bloomfield, P.
    Houle, S.
    Kapur, S.
    Wilson, A.
    NEUROIMAGE, 2006, 31 : T30 - T30
  • [25] Estimating Endogenous Dopamine Levels at D2 and D3 Receptors in Humans using the Agonist Radiotracer [11C]-(+)-PHNO
    Fernando Caravaggio
    Shinichiro Nakajima
    Carol Borlido
    Gary Remington
    Philip Gerretsen
    Alan Wilson
    Sylvain Houle
    Mahesh Menon
    David Mamo
    Ariel Graff-Guerrero
    Neuropsychopharmacology, 2014, 39 : 2769 - 2776
  • [26] Estimating Endogenous Dopamine Levels at D2 and D3 Receptors in Humans using the Agonist Radiotracer [11C]-(+)-PHNO
    Caravaggio, Fernando
    Nakajima, Shinichiro
    Borlido, Carol
    Remington, Gary
    Gerretsen, Philip
    Wilson, Alan
    Houle, Sylvain
    Menon, Mahesh
    Mamo, David
    Graff-Guerrero, Ariel
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (12) : 2769 - 2776
  • [27] Estimating Endogenous Dopamine Levels at D2 and D3 Receptors in Humans Using the Agonist Radiotracer [11C]-(+)-PHNO
    Graff, Ariel
    Caravaggio, Fernando
    Nakajima, Shinichiro
    Gerretsen, Philip
    Mamo, David
    Remington, Gary
    Wilson, Alan A.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S240 - S240
  • [28] PET imaging of dopamine D3 receptors in humans with [11C]-(+)-PHNO: dissection of PHNO signal using two highly selective D3 antagonists
    Searle, Graham E.
    Beaver, John D.
    Iavarone, Laura E.
    Comley, Robert A.
    Bani, Massimo
    Tziortzi, Andri
    Slifstein, Mark
    Wilson, Alan A.
    Gunn, Roger N.
    Rabiner, Eugenii A.
    Laruelle, Marc
    NEUROIMAGE, 2010, 52 : S20 - S21
  • [29] Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO
    Slifstein, Mark
    Abi-Darghami, Anissa
    Girgis, Ragy R.
    Suckow, Raymond F.
    Coopers, Thomas B.
    Divgi, Chaitanya R.
    Sokoloff, Pierre
    Leriche, Ludovic
    Carberry, Patrick
    Oya, Shunichi
    Joseph, Simon K.
    Guiraud, Marlene
    Montagne, Agnes
    Brunner, Valerie
    Gaudoux, Florence
    Tonner, Francoise
    PSYCHOPHARMACOLOGY, 2020, 237 (02) : 519 - 527
  • [30] Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO
    Mark Slifstein
    Anissa Abi-Dargham
    Ragy R Girgis
    Raymond F Suckow
    Thomas B Cooper
    Chaitanya R Divgi
    Pierre Sokoloff
    Ludovic Leriche
    Patrick Carberry
    Shunichi Oya
    Simon K Joseph
    Marlène Guiraud
    Agnès Montagne
    Valérie Brunner
    Florence Gaudoux
    Françoise Tonner
    Psychopharmacology, 2020, 237 : 519 - 527